30 September, 2010
Last week, an Avandia recall in Europe was announced as the FDA put tight new restrictions on Avandia use in the United States.
Avandia has been on the market in the U.S. to treat type 2 diabetes since 1999. How long have drug maker GlaxoSmithKline and the FDA been aware of Avandia side effects risks? According to a lead Senate investigator, the answer is shocking. Continue reading Avandia Recall News: GSK hid Rosiglitazone side effects risks
25 September, 2010
Statutes of limitation are laws that set the time limit for filing lawsuits
If an Avandia lawsuit is not filed before the legal deadline, any potential claim to an Avandia settlement may be lost. Several factors can affect the amount of time you have to file an Avandia lawsuit. Continue reading Avandia settlement time limits : Lawsuit statute of limitations
Category: Avandia Lawsuit | Avandia Settlements25 September, 2010
FDA stops Avandia TIDE trial due to unjustified risk of stroke and cardiac events.
Act now to make you Avandia settlement claim. FDA drug safety experts concluded that the TIDE trial subjected participants to an unjustified risk of heart disease. All of the regulatory deadlines set by the FDA for completion of the trial have been rescinded. Continue reading FDA stops Avandia TIDE trial due to unjustified heart risks
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety23 September, 2010
The attorneys at AvandiaRecallNews.com no longer are accepting new Avandia cases.
Makes regulatory decisions on RECORD and TIDE trials
[09-23-2010] The U.S. Food and Drug Administration today announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with… Continue reading New FDA Avandia restrictions: 9-23-2010 FDA News Release
Category: Avandia FDA Alerts23 September, 2010
The FDA announced today that it will put tight restrictions on Avandia use while the EMA announced a European Avandia recall.
Under new FDA Avandia restrictions, the diabetes drug will be available in the U.S. to new patients, “only if they are unable to achieve glucose control on other medications and are unable to take Actos (pioglitazone), the only other drug in this class.” Continue reading FDA: Avandia restricted severly; Europe: Avandia recall
Category: Avandia FDA | Avandia News | Avandia Recall19 September, 2010
Avandia settlements in 2010 have been won on thousands of legal claims against drug company GlaxoSmithKline. Settlement amounts vary depending on the facts of each case.
Law firm Tuteur & Associates, LLC currently is accepting Avandia lawsuit cases in all 50 states. The 2010 Avandia lawsuits seek financial compensation from GSK for personal injury and wrongful death damages suffered after taking the type 2 diabetes drug. Continue reading Avandia Settlement Amounts - 2010 Avandia Lawsuit
Category: Avandia Lawsuit | Avandia Settlements18 September, 2010
The FDA has begun reviewing the safety of the diabetes drug Actos (pioglitazone), after receiving early results from research evaluating the drug’s bladder cancer risk.
While early data from a long-term study demonstrates an increased risk of bladder cancer in patients with the longest exposure and in those having taken the highest cumulative dose of Actos, the FDA has not concluded that Actos increases the risk of bladder cancer. The FDA has no clinical information associating Avandia with bladder cancer. Continue reading FDA reviewing safety of Avandia's rival diabetes drug Actos
Category: Avandia FDA | Avandia News | Avandia Safety | Uncategorized13 September, 2010
FDA officials in favor of an Avandia recall claim drug safety advisory committee panelists were biased in favor of the diabetes drug.
FDA drug safety experts Dr. David Graham and Dr. Kate Galperin sharply criticized the agency for including consultants who were biased against an Avandia recall on a 2010 FDA drug advisory panel. This most recent criticism of FDA Avandia review was published in the British Medical Journal on September 7, 2010. Continue reading Drug safety expert at FDA: Avandia panel had anti-recall bias
Category: Avandia FDA | Avandia News | Avandia Recall9 September, 2010
Concerns over Avandia side effects has led an independent panel of drug safety experts in England to call for an Avandia recall.
The Medicines and Healthcare Products Regulatory Agency (MHRA) is the Brittish counterpart to the U.S. FDA. Avandia side effects risks outweigh its benefits, the regulators were advised by the panel. Continue reading Drug experts call for UK Avandia recall due to side effects
Category: Avandia News | Avandia Recall | Avandia Safety | Avandia Side Effects